These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6764605)

  • 21. [Functional improvement of the aging brain: placebo controlled pharmaco-EEG and psychometric studies with a metabolically active hemoderivative (Actovegin)].
    Saletu B; Grünberger J; Linzmayer L; Stöhr H
    Z Gerontol; 1984; 17(5):271-9. PubMed ID: 6395527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The pharmacokinetics of nomifensine. Comparison of pharmacokinetics and pharmacodynamics using computer pharmaco-EEG.
    Saletu B; Grünberger J; Linzmayer L; Taeuber K
    Int Pharmacopsychiatry; 1982; 17 Suppl 1():43-72. PubMed ID: 7129805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of methods for the assessment of central nervous system stimulant response after dextroamphetamine administration to healthy male volunteers.
    Slattum PW; Venitz J; Barr WH
    J Clin Pharmacol; 1996 Nov; 36(11):1039-50. PubMed ID: 8973993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psychophysiological and psychometric studies after manipulating the GABA system by vigabatrin, a GABA-transaminase inhibitor.
    Saletu B; Grünberger J; Linzmayer L; Schwartz JJ; Haegele KD; Schechter PJ
    Int J Psychophysiol; 1986 May; 4(1):63-80. PubMed ID: 3721943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EEG brain mapping in evaluating the time-course of the central action of DUP 996--a new acetylcholine releasing drug.
    Saletu B; Darragh A; Salmon P; Coen R
    Br J Clin Pharmacol; 1989 Jul; 28(1):1-16. PubMed ID: 2775607
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacodynamic and pharmacokinetic profile of S 17092, a new orally active prolyl endopeptidase inhibitor, in elderly healthy volunteers. A phase I study.
    Morain P; Robin JL; De Nanteuil G; Jochemsen R; Heidet V; Guez D
    Br J Clin Pharmacol; 2000 Oct; 50(4):350-9. PubMed ID: 11012558
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic and -dynamic studies with a new anxiolytic, suriclone, utilizing EEG mapping and psychometry.
    Saletu B; Grünberger J; Linzmayer L; Semlitsch HV; Anderer P; Chwatal K
    Br J Clin Pharmacol; 1994 Feb; 37(2):145-56. PubMed ID: 7910470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute central effects of the calcium channel blocker and antiglutamatergic drug caroverine. Double-blind, placebo-controlled, EEG mapping and psychometric studies after intravenous and oral administration.
    Saletu B; Grünberger J; Anderer P; Linzmayer L; König P
    Arzneimittelforschung; 1995 Mar; 45(3):217-29. PubMed ID: 7741773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Visualizing central effects of S-adenosyl-L-methionine (SAMe), a natural molecule with antidepressant properties, by pharmaco-EEG mapping.
    Saletu-Zyhlarz GM; Anderer P; Linzmayer L; Semlitsch HV; Assandri A; Prause W; Hassan Abu-Bakr M; Lindeck-Pozza E; Saletu B
    Int J Neuropsychopharmacol; 2002 Sep; 5(3):199-215. PubMed ID: 12366873
    [TBL] [Abstract][Full Text] [Related]  

  • 30. On acute and chronic CNS effects of antidepressants in normals: neurophysiological, behavioral and pharmacokinetic studies with pirlindol.
    Saletu B; Grünberger J
    Methods Find Exp Clin Pharmacol; 1985 Mar; 7(3):137-51. PubMed ID: 4010387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmaco-EEG profiles of antidepressants. Pharmacodynamic studies with fluvoxamine.
    Saletu B; Grünberger J; Rajna P
    Br J Clin Pharmacol; 1983; 15 Suppl 3(Suppl 3):369S-383S. PubMed ID: 6407499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. EEG brain mapping and psychometry in age-associated memory impairment after acute and 2-week infusions with the hemoderivative Actovegin: double-blind, placebo-controlled trials.
    Saletu B; Grünberger J; Linzmayer L; Anderer P; Semlitsch HV
    Neuropsychobiology; 1990-1991; 24(3):135-48. PubMed ID: 2135068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spontaneous and drug-induced remission of alcoholic organic brain syndrome: clinical, psychometric, and neurophysiological studies.
    Saletu B; Saletu M; Grünberger J; Mader R
    Psychiatry Res; 1983 Sep; 10(1):59-75. PubMed ID: 6580659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative pharmacodynamic studies with the novel serotonin uptake-enhancing tianeptine and -inhibiting fluvoxamine utilizing EEG mapping and psychometry.
    Saletu B; Grünberger J; Anderer P; Linzmayer L; Zyhlarz G
    J Neural Transm (Vienna); 1996; 103(1-2):191-216. PubMed ID: 9026373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmaco-EEG, behavioural methods and blood levels in the comparison of temazepam and flunitrazepam.
    Saletu B; Grünberger J; Sieghart W
    Acta Psychiatr Scand Suppl; 1986; 332():67-94. PubMed ID: 2883830
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative bioavailability studies with a new mixed-micelles solution of diazepam utilizing radioreceptor assay, psychometry and EEG brain mapping.
    Saletu B; Anderer P; Kinsperger K; Grünberger J; Sieghart W
    Int Clin Psychopharmacol; 1988 Oct; 3(4):287-323. PubMed ID: 3235816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Classification and bioavailability studies with WE 941 by quantitative pharmaco-EEG and clinical analyses.
    Saletu B; Grünberger J; Volavka J; Berner P
    Arzneimittelforschung; 1979; 29(4):700-4. PubMed ID: 582772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Double-blind, placebo-controlled, multiple-ascending-dose study on the pharmacodynamics of ABIO-08/01, a new CNS drug with potential anxiolytic activity. 1. EEG mapping, psychometric and tolerability findings.
    Saletu-Zyhlarz GM; Anderer P; Wolzt M; Semlitsch HV; Assandri A; Nessi P; Nannipieri F; Rosini S; Saletu B
    Neuropsychobiology; 2009; 59(2):100-9. PubMed ID: 19365150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Double-blind, placebo-controlled, pharmacokinetic and -dynamic studies with 2 new formulations of piracetam (infusion and sirup) under hypoxia in man.
    Saletu B; Hitzenberger G; Grünberger J; Anderer P; Zyhlarz G; Linzmayer L; Rameis H
    Int J Clin Pharmacol Ther; 1995 May; 33(5):249-62. PubMed ID: 7655763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Double-blind, placebo-controlled, multiple-ascending-dose study on the pharmacodynamics of ABIO-08/01, a new CNS drug with potential anxiolytic activity. 2. EEG-tomography findings based on LORETA (low-resolution brain electromagnetic tomography).
    Saletu B; Anderer P; Wolzt M; Nosiska D; Assandri A; Noseda E; Nannipieri F; Saletu-Zyhlarz GM
    Neuropsychobiology; 2009; 59(2):110-22. PubMed ID: 19365151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.